blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0666739

EP0666739 - AN INTRAVENOUS SOLUTION THAT DIMINISHES BODY PROTEIN AND WATER LOSS [Right-click to bookmark this link]
Former [1995/33]AN INTRAVENOUS SOLUTION THAT DIMINISHES BODY PROTEIN LOSS
[2001/01]
StatusNo opposition filed within time limit
Status updated on  22.11.2002
Database last updated on 12.10.2024
Most recent event   Tooltip22.11.2002No opposition filed within time limitpublished on 08.01.2003  [2003/02]
Applicant(s)For all designated states
THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
75 Francis Street
Boston, MA 02115 / US
[2001/30]
Former [1995/33]For all designated states
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis Street
Boston, Massachusetts 02115 / US
Inventor(s)01 / WILMORE, Douglas
125 Rockwood Street
Brookline, MA 02146 / US
[1995/33]
Representative(s)Wibbelmann, Jobst, et al
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstrasse 2
81541 München / DE
[N/P]
Former [1995/33]Wibbelmann, Jobst, Dr., et al
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstrasse 2
D-81541 München / DE
Application number, filing date94900537.505.11.1993
[1995/33]
WO1993US10621
Priority number, dateUS1992097162306.11.1992         Original published format: US 971623
[1995/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9410988
Date:26.05.1994
Language:EN
[1994/12]
Type: A1 Application with search report 
No.:EP0666739
Date:16.08.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 26.05.1994 takes the place of the publication of the European patent application.
[1995/33]
Type: B1 Patent specification 
No.:EP0666739
Date:16.01.2002
Language:EN
[2002/03]
Search report(s)International search report - published on:US26.05.1994
(Supplementary) European search report - dispatched on:EP10.01.1996
ClassificationIPC:A61K31/13, A61K31/70, A61K31/195, A23L1/305
[1996/08]
CPC:
A61K31/195 (EP,US); Y10S426/804 (EP,US); Y10S426/81 (EP,US)
Former IPC [1995/33]A61K31/13, A61K31/70
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/33]
TitleGerman:INTRAVENÖSE LÖSUNG, DIE DEN PROTEIN - UND WASSERVERLUST IM KÖRPER REDUZIERT[2001/43]
English:AN INTRAVENOUS SOLUTION THAT DIMINISHES BODY PROTEIN AND WATER LOSS[2001/43]
French:SOLUTION INTRAVEINEUSE QUI REDUIT LA PERTE DES PROTEINES ET D'EAU DANS LE CORPS[2001/43]
Former [1995/33]Intravenöse Lösung, die den Prpteinverlust im Körper reduziert
Former [1995/33]AN INTRAVENOUS SOLUTION THAT DIMINISHES BODY PROTEIN LOSS
Former [1995/33]SOLUTION INTRAVEINEUSE QUI REDUIT LA PERTE DE PROTEINES DANS LE CORPS
Entry into regional phase05.05.1995National basic fee paid 
05.05.1995Search fee paid 
05.05.1995Designation fee(s) paid 
05.05.1995Examination fee paid 
Examination procedure06.06.1994Request for preliminary examination filed
International Preliminary Examining Authority: US
05.05.1995Examination requested  [1995/33]
15.10.1998Despatch of a communication from the examining division (Time limit: M04)
10.02.1999Reply to a communication from the examining division
08.03.1999Despatch of a communication from the examining division (Time limit: M06)
20.08.1999Reply to a communication from the examining division
21.12.1999Despatch of a communication from the examining division (Time limit: M06)
30.06.2000Reply to a communication from the examining division
14.11.2000Date of oral proceedings
24.11.2000Minutes of oral proceedings despatched
28.11.2000Despatch of communication of intention to grant (Approval: Yes)
08.06.2001Communication of intention to grant the patent
23.08.2001Fee for grant paid
23.08.2001Fee for publishing/printing paid
Opposition(s)17.10.2002No opposition filed within time limit [2003/02]
Fees paidRenewal fee
16.11.1995Renewal fee patent year 03
26.02.1997Renewal fee patent year 04
10.11.1997Renewal fee patent year 05
10.11.1998Renewal fee patent year 06
08.11.1999Renewal fee patent year 07
10.11.2000Renewal fee patent year 08
07.11.2001Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.11.199604   M06   Fee paid on   26.02.1997
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9101135  (KABIVITRUM AB [SE]) [A] 1-6 * example -; claim - *;
 [A]WO9209277  (KABI PHARMACIA AB [SE]) [A] 1-6* claim - *
International search[A]US1909591  (MENDEL NEVIN);
 [A]US2283817  (MARTIN GUSTAV J, et al);
 [A]US2662046  (HOWE EUGENE E);
 [A]US2868693  (WILLIAM SHIVE, et al);
 [A]US3195778  (EDWIN COATES J);
 [A]US3217711  (PECINA RICHARD W, et al);
 [A]US3574857  (CEVALLOS WILLIAM H);
 [A]US3701666  (WINITZ MILTON);
 [A]US3793450  (SCHNELL J);
 [A]US3832465  (GHADIMI H);
 [A]US3920838  (FLATT JEAN-PIERRE, et al);
 [A]US3950529  (FISCHER JOSEF E, et al);
 [A]US3982534  (BUCKMAN THOMAS P);
 [A]US3988466  (TAKAGI KEIJIRO, et al);
 [A]US4200095  (RETI ADRIAN R [US]);
 [A]US4265240  (JENKINS JON A);
 [A]US4334535  (WILSON DAVID A, et al);
 [A]US4396383  (HART JOHN W);
 [A]US4439448  (MUNAKATA HIROAKI [JP], et al);
 [A]US4857555  (SMITH ROBERT J [US], et al);
 [A]US5039704  (SMITH ROBERT J [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.